Category Archives for "News"

Abattis Announces Completion of Investment by Emerald Health Therapeutics in Northern Vine

Abattis Announces Completion of Investment by Emerald Health Therapeutics in Northern Vine Emerald and Abattis positioned to grow analytical testing and import opportunities facilitated by Northern Vines’ recently renewed Licensed Dealer Laboratory NOVEMBER 21, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the closing of its […]

Read More

Abattis Announces Strategic Investment into Northern Vine and Partnership with Emerald Health Therapeutics

Abattis Announces Strategic Investment into Northern Vine and Partnership with Emerald Health Therapeutics OCTOBER 26, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce it has signed a definitive agreement with Emerald Health Therapeutics Inc. (“Emerald” or “Emerald Health”) (TSXV:EMH) involving the wholly-owned Abattis laboratory […]

Read More

Abattis signs definitive distribution agreement with GD Pharma to sell Abattis products in South Korea

Abattis signs definitive distribution agreement with GD Pharma to sell Abattis products in South Korea OCTOBER 3, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce it has reached a definitive agreement with Global Damon Pharma (“GD Pharma”) of South Korea, to distribute and sell Abattis’ […]

Read More

Abattis regains 100% ownership in Northern Vine to focus and expand on Lab and Extraction strategy

Abattis regains 100% ownership in Northern Vine to focus and expand on Lab and Extraction strategy SEPTEMBER 26, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce it has signed a settlement agreement returning 100% ownership in its laboratory subsidiary, Northern Vine Canada Inc. (“Northern […]

Read More

Abattis provides important update on Northern Vine and Sales Division

Abattis provides important update on Northern Vine and Sales Division SEPTEMBER 13, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an important update regarding its subsidiaries Northern Vine Canada Inc. (“Northern Vine”) and Vergence Naturals Ltd. (“Vergence”). “We are very pleased with the continued […]

Read More

Abattis Announces Breakthrough CBD-Based Sunscreen Formulation

Abattis Announces Breakthrough CBD-Based Sunscreen Formulation AUGUST 28, 2017    |    Abattis Bioceuticals VANCOUVER, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce a breakthrough CBD-based sunscreen formulation, developed by Abattis through its majority-owned subsidiary, Northern Vine Canada Inc. (“Northern Vine”), and […]

Read More